Legato Capital Management LLC Buys 3,467 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Legato Capital Management LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 57.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,500 shares of the medical equipment provider's stock after purchasing an additional 3,467 shares during the period. Intuitive Surgical comprises 0.6% of Legato Capital Management LLC's holdings, making the stock its 23rd largest position. Legato Capital Management LLC's holdings in Intuitive Surgical were worth $4,705,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of ISRG. Norges Bank bought a new position in Intuitive Surgical during the fourth quarter valued at $2,401,493,000. GAMMA Investing LLC boosted its holdings in shares of Intuitive Surgical by 54,010.7% in the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock worth $14,999,630,000 after acquiring an additional 3,022,979 shares during the period. Capital Research Global Investors boosted its stake in Intuitive Surgical by 25.5% during the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock valued at $1,764,904,000 after buying an additional 687,906 shares during the period. Northern Trust Corp boosted its stake in Intuitive Surgical by 15.8% during the fourth quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock valued at $1,889,126,000 after buying an additional 494,496 shares during the period. Finally, GQG Partners LLC boosted its stake in Intuitive Surgical by 42.5% during the fourth quarter. GQG Partners LLC now owns 1,145,300 shares of the medical equipment provider's stock valued at $597,801,000 after buying an additional 341,812 shares during the period. 83.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have weighed in on ISRG shares. Evercore ISI raised their price target on Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research report on Tuesday, July 8th. Piper Sandler restated an "overweight" rating and set a $595.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday. UBS Group boosted their price target on Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a report on Wednesday. Truist Financial lifted their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a research report on Wednesday. Finally, Wells Fargo & Company lifted their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a research report on Wednesday. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $592.05.

Intuitive Surgical Stock Up 1.5%

ISRG traded up $7.25 during mid-day trading on Friday, reaching $495.86. 1,870,941 shares of the company traded hands, compared to its average volume of 1,842,693. The stock has a market capitalization of $177.73 billion, a P/E ratio of 69.16, a P/E/G ratio of 5.45 and a beta of 1.64. The company's fifty day moving average price is $529.86 and its 200-day moving average price is $535.13. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company's quarterly revenue was up 21.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.78 EPS. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, SVP Mark Brosius sold 216 shares of the company's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president directly owned 907 shares in the company, valued at $510,740.77. This represents a 19.23% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Myriam Curet sold 4,500 shares of the company's stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares of the company's stock, valued at $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 7,798 shares of company stock valued at $3,955,331. Company insiders own 0.70% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.